This page includes the latest FDA filings for Delcath Systems Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | OTHER OTC Market | DCTH | DUNS 847060225 |
Registration Number | 3008822486 |
FEI Number | 3008822486 |
Name | Delcath Systems, Inc. |
Owner & Operator | Delcath Systems, Inc. |
Contact Address | 1633 Broadway Suite 22C New York NY 10019 US |
Official Correspondent |
|
Registration Status | 1 |
Initial Importer | N |
Registration Expiration | 2020-04-25 |
Registration Address | 566 Queensbury Ave Queensbury, NY 12804 US |
Establishment Type | Manufacture Device in the United States for Export Only |
Device Company | Device | Date |
---|---|---|
Delcath Systems, Inc. | Prescription Medication | 2024-11-24 |
Delcath Systems, Inc. | Prescription Medication | 2024-07-24 |
Delcath Systems, Inc. | Prescription Medication | 2024-06-20 |
Delcath Systems, Inc. | Prescription Medication | 2024-03-02 |
Delcath Systems, Inc. | Prescription Medication | 2023-12-08 |
Delcath Systems, Inc. | Hepatic CHEMOSAT Delivery System | 2011-05-09 |
SEC | 0001312104 | Delcath Systems Inc |
SEC | 0000872912 | DELCATH SYSTEMS, INC. of DELAWARE |